Our technology

A revolution in drug discovery & development

Drug development is a complex, time-consuming and resource intensive process that often fails to cross the finish line.

Computer assisted drug design (CADD) has long failed to live up to it's promise to streamline that process and deliver truly insightful information to help design better drugs. HTuO's physics-based technology addresses the root of the issue.

Learn More

Our Mission

Minimizing the error of simulations

For protein scale simulations, it is imperative that the error introduced by approximations in the underlying force field be as small as possible, which is the goal of HTuO’s development process: to get ever closer to accurate simulations with minimal error.

About Us
HtuO Bioscience molecule

The HTuO advantage

Introducing high accuracy into modeling gives us and our partners the ability to address the challenges of drug design head-on. A more detailed understanding of how molecules interact allows for data-driven predictions of the best possible drug design - ultimately leading to fewer drugs failing and more efficacious drugs.

Icon discovery
Target Market

Learn more about our potential in the drug discovery & our long term vision.
Applications

Icon discovery
Collaboration

We are happy to discuss any form of a collaboration to let you access our platform.
Partnerships

Icon discovery
Careers

We are always on the lookout for talent. We’re open to fixed location and remote work. See Careers

Team Image

Interested in working with us?

Join the HTuO Team

Check our Careers page for open positions, and see if we have the right opportunity for you.

Open Positions

Recent News & Events

Apr 16, 2024

Our CEO, Dr. Anthony Fejes, and Director of Business Development, Mr. Jacek Mis, will be in San Diego, June 3-6 at the 2024 BIO International Convention. Connect with us through the partnering portal or email us directly to learn about our technology and its drug discovery potential.

February 23, 2024

We are pleased to announce that HTuO Biosciences received The Most Promising Pitch award at Angel Forum’s 5th Western Angel Investment Summit in Victoria.

February 12, 2024

We are exited to announce that HTuO has joined Johnson & Johnson Innovation JLABS in San Francisco. For more information, please read the press release.